2012
DOI: 10.1371/journal.pone.0031111
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Prostamide F2α and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability

Abstract: It was suggested that endocannabinoids are metabolized by cyclooxygenase (COX)-2 in the spinal cord of rats with kaolin/λ-carrageenan-induced knee inflammation, and that this mechanism contributes to the analgesic effects of COX-2 inhibitors in this experimental model. We report the development of a specific method for the identification of endocannabinoid COX-2 metabolites, its application to measure the levels of these compounds in tissues, and the finding of prostamide F2α (PMF2α) in mice with knee inflamma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
92
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(96 citation statements)
references
References 28 publications
4
92
0
Order By: Relevance
“…PGF 2 ␣ -EA is involved in infl ammatory pain and dorsal horn nociceptive neuron excitability, while PGE 2 -EA increases blood fl ow and reduces mean arterial pressure in the renal medulla, exhibits strong neuroprotective properties in cerebellar neurons, and along with PGD 2 -EA, induces apoptosis in an in vitro model of colorectal carcinoma (18)(19)(20)(21). Prostamides do not show potent interaction with prostanoid receptors, and studies using isolated feline iris cells have suggested the presence of prostamide-sensitive receptors different from the ones responding to PGs (22)(23)(24).…”
Section: Tissue Homogenization and Extraction Of Prostamides And Fattmentioning
confidence: 99%
“…PGF 2 ␣ -EA is involved in infl ammatory pain and dorsal horn nociceptive neuron excitability, while PGE 2 -EA increases blood fl ow and reduces mean arterial pressure in the renal medulla, exhibits strong neuroprotective properties in cerebellar neurons, and along with PGD 2 -EA, induces apoptosis in an in vitro model of colorectal carcinoma (18)(19)(20)(21). Prostamides do not show potent interaction with prostanoid receptors, and studies using isolated feline iris cells have suggested the presence of prostamide-sensitive receptors different from the ones responding to PGs (22)(23)(24).…”
Section: Tissue Homogenization and Extraction Of Prostamides And Fattmentioning
confidence: 99%
“…Artificially elevating EC levels can unmask alternative metabolic routes, producing additional bioactive products. Interestingly, pathological conditions such as chronic pain states are associated with changes in levels of enzymes, such as cyclooxygenase (COX), lipoxygenase, αβ hydrolase and members of the cytochrome P450 family (122)(123)(124)(125) , which can metabolise the EC to novel lipid signalling molecules. The physiological actions of these metabolic products are as yet unknown, but some preliminary investigations have been performed.…”
Section: Novel Metabolic Pathwaysmentioning
confidence: 99%
“…It also reduced adipogenic responses to bimatoprost (Silvestri et al, 2013). In a study involving prostamide F 2a , as opposed to bimatoprost, AGN 211336 reduced the nociceptive neuronal firing and behavioral response to spinal application of prostamide F 2a (Gatta et al, 2012). Finally, a very close congener AGN 211335, provided invaluable pharmacological support for those studies intended to clone the prostamide receptor .…”
Section: B Antagonistsmentioning
confidence: 95%
“…The discovery of prostamide/PGF synthase and its distribution (Moriuchi et al, 2008) was not only instrumental in defining prostamide F 2a as an endogenous prostamide (Gatta et al, 2012), it also provided direction for further investigation of biologic roles. In adult mice, prostamide/PGF synthase was found to be widely expressed in the brain, predominantly in the white matter (Yoshikawa et al, 2011).…”
Section: Central Nervous Systemmentioning
confidence: 99%